Navigation Links
Wyeth Reduces Risk with Dyadem Software
Date:4/2/2009

TORONTO, April 2 /PRNewswire/ -- Dyadem, the market leader in Quality Lifecycle Management and Risk Lifecycle Management solutions, has announced that Wyeth, a global leader in prescription pharmaceuticals and non-prescription consumer health care products, is using software from Dyadem to enhance and standardize its risk assessments. Dyadem's PHA-Pro, a software solution that identifies, measures and mitigates risk, enables Wyeth to set a new standard in safety for its pharmaceutical products. Wyeth's industry-leading pharmaceutical and health care products improve lives and deliver outstanding value to customers and shareholders by leading the world in innovation through pharmaceutical, biotech and vaccine technologies.

PHA-Pro is a software solution that delivers industry-standard Process Hazard Analysis (PHA) capabilities for the process industries. The PHA methodology is an integral part of a pharmaceutical manufacturer's Process Safety Management program and results in safer and more predictable production processes. Dyadem's PHA-Pro helps manage Risk Lifecycle Management processes, and was built to reflect the risk mitigation initiatives and operating environments of the various process industries. This is essential to optimizing work time, minimizing work stoppages, and reducing the potential for undesirable events, while improving the safety and quality of a given product for consumers.

With PHA-Pro being used across their global organization, Wyeth has integrated the knowledge and expertise of all departments into their PHA studies and provided the Environmental Health and Safety department visibility into the overall business process, making everyone at the company more aware of their global business and safety strategy. "We needed a systematic, methodical way to document our PHA studies," said Steven Meszaros, Corporate Director, EHS (Environmental Health and Safety), Wyeth. "With Dyadem's PHA-Pro, Wyeth has been able to establish a community of users and a standardized approach to our PHA studies. It has allowed us to create a benchmark for safety and quality for our company, which will ultimately benefit our customers."

Having used PHA-Pro for many years, Wyeth has been able to continuously improve their risk management program. The easy configuration of templates, along with the application's industry-specific libraries and report-generating features have allowed Wyeth to focus on their business process and overall business strategy, instead of worrying about the consistency of their PHA studies. Since implementing PHA-Pro, Wyeth has been able to establish a best-practice platform which has proven to management the value of a consistent hazard review process across the network.

"Wyeth's commitment to safety and visibility for all departments are some of the reasons it has remained a leader in the pharmaceutical industry," said Kevin North, President and CEO of Dyadem. "Pharmaceutical companies have traditionally had challenges ensuring consistency and accuracy in their risk assessments, but with our Risk Lifecycle Management solutions, we have given the industry a chance to address this. Wyeth shows how important it is to standardize risk mitigation initiatives, and provide an avenue for input from all areas of a business. Through their commitment to product safety, Wyeth proves how easy it is to create safe, quality products and still be on the leading edge of innovation."

About Dyadem

Dyadem is the market leader in Quality Lifecycle Management and Risk Lifecycle Management solutions. Dyadem provides software and services that empower companies to manage quality, mitigate risks, achieve regulatory compliance, plan for business continuity and improve profitability. Dyadem works with 85% of the Fortune 500 companies and serves the high tech & electronics, medical devices, oil and gas, chemical, automotive, pharmaceutical and aerospace and defense industries. For more information, visit www.dyadem.com

About Wyeth

Wyeth is a global leader in prescription pharmaceuticals, non-prescription consumer health care products, and pharmaceuticals for animal health. Wyeth's products are sold in more than 145 countries, and its product portfolio includes innovative treatments across a wide range of therapeutic areas. Wyeth's worldwide resources include 47,500 employees, manufacturing facilities on four continents, and a unique research and technology base encompassing small molecules, biopharmaceuticals, genetic engineering that will give us the next wave of innovative therapies, and vaccines. With this depth of resources, Wyeth will continue to lead the way in the development of novel therapies that address critical global health needs. For more information, visit www.wyeth.com.

    For further information, contact:
    Text 100 Public Relations
    Kevin Doak
    617.399.4931
    dyadem@text100.com


'/>"/>
SOURCE Dyadem
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Wyeth and Nycomed Announce Court Denial of Preliminary Injunction
2. Wyeths Pearl River, N.Y. Facility Celebrates 100 Years of Achievements in Health care
3. Wyeth Announces Election of Bernard Poussot as CEO of Company Effective January 1, 2008
4. Wyeth Announces the Election of Robert M. Amen to Its Board of Directors
5. Wyeth Comments on PREVNAR and Trends in Pneumococcal Disease
6. Wyeth to Appeal Nevada Hormone Therapy Trial Verdict
7. Wyeth Reports Earnings Results for the 2007 Third Quarter and First Nine Months
8. Wyeth Consumer Healthcare Initiates Voluntary Recall and Replacement Program for Several Robitussin Products and Childrens Dimetapp Cold & Chest Congestion
9. Wyeth Consumer Healthcare Announces the Availability of Centrum Cardio and New Formula Centrum Products
10. Wyeth to Present at the Credit Suisse First Boston Healthcare Conference
11. Wyeth Receives FDA Approval of Protonix for Delayed-Release Oral Suspension
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... ... they have been diagnosed with endometriosis. These women need a treatment plan to ... a comprehensive approach that can help for preservation of fertility and ultimately achieving ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... ... the United States, named Dr. Sesan Ogunleye, as the Medical Director of its new ... the facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... are unfamiliar with. The article goes on to state that individuals are now more ... these less common operations such as calf and cheek reduction. The Los Angeles area ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
(Date:6/24/2016)... ... 24, 2016 , ... EB Medicine presented its first-ever “Issue ... conference in Ponte Vedra Beach, FL. The awards honor the outstanding work of ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)...  In a startling report released today, National Safety Council ... a comprehensive, proven plan to eliminate prescription opioid overdoses. ... states are tackling the worst drug crisis in recorded U.S. history, ... Kentucky , New Mexico , ... the 28 failing states, three – Michigan , ...
(Date:6/23/2016)... WAYNE, Pa. , June 23, 2016 ... provider, will launch its next generation clinical outcomes platform, Bracket ... DIA Meeting held on June 26 – 30, 2016 in ... 6.0, the first electronic Clinical Outcome Assessment product of its ... DIA Booth #715. Bracket eCOA 6.0 is a ...
Breaking Medicine Technology: